REGULATED PRESS RELEASE published on 10/28/2025 at 17:35, 10 months 25 days ago Disclosure of transactions in own shares from October 20 to October 24, 2025
REGULATED PRESS RELEASE published on 10/28/2025 at 17:35, 10 months 25 days ago Déclaration hebdomadaire d'opérations effectuées du 20 au 24 octobre 2025
BRIEF published on 10/22/2025 at 07:30, 11 months 1 day ago Kurma Partners vend ImCheck Therapeutics à Ipsen pour jusqu'à 1 milliard d'euros Kurma Partners ImCheck Therapeutics Cession Ipsen Cancer Immunothérapie Investissement Eurazeo
BRIEF published on 10/22/2025 at 07:30, 11 months 1 day ago Kurma Partners Sells ImCheck Therapeutics to Ipsen for Up to €1 Billion Cancer Immunotherapy Biotech Investments Kurma Partners ImCheck Therapeutics Ipsen Acquisition
REGULATED PRESS RELEASE published on 10/22/2025 at 07:25, 11 months 1 day ago KURMA PARTNERS, MEMBRE DU GROUPE EURAZEO ET ACTIONNAIRE-FONDATEUR D’IMCHECK, ANNONCE LA CESSION DE LA BIOTECH A IPSEN POUR UN MONTANT POUVANT ATTEINDRE 1 MILLIARD D’EUROS KURMA PARTNERS cède ImCheck Therapeutics à IPSEN pour 1 milliard d’euros après succès dans la création et développement d'anticorps d'immunothérapie Cession Biotechnologie Ipsen Kurma Partners ImCheck Therapeutics
REGULATED PRESS RELEASE published on 10/22/2025 at 07:25, 11 months 1 day ago KURMA PARTNERS, A MEMBER OF THE EURAZEO GROUP AND FOUNDING INVESTOR OF IMCHECK THERAPEUTICS, ANNOUNCES THE SALE OF THE BIOTECH COMPANY TO IPSEN FOR UP TO €1 BILLION Kurma Partners, a member of the Eurazeo group, announces the sale of ImCheck Therapeutics to Ipsen for up to €1 billion. The biotech company focuses on immunotherapy for cancer treatment, confirming Kurma's success in creating and supporting biotech ventures Immunotherapy Biotech Company Ipsen Kurma Partners ImCheck Therapeutics
REGULATED PRESS RELEASE published on 10/20/2025 at 17:35, 11 months 2 days ago Disclosure of transactions in own shares from October 13 to October 17, 2025
REGULATED PRESS RELEASE published on 10/20/2025 at 17:35, 11 months 2 days ago Déclaration hebdomadaire d'opérations effectuées du 13 au 17 octobre 2025
REGULATED PRESS RELEASE published on 10/13/2025 at 17:35, 11 months 9 days ago Déclaration hebdomadaire d'opérations effectuées du 6 au 10 octobre 2025
REGULATED PRESS RELEASE published on 10/13/2025 at 17:35, 11 months 9 days ago Disclosure of transactions in own shares from October 6 to October 10, 2025
Published on 09/23/2026 at 08:00, 36 minutes ago Caledonia Mining Corporation Plc: Notification of Relevant Change to Significant Shareholder
Published on 09/23/2026 at 07:30, 1 hour 6 minutes ago Tocvan Expands El Mezquite; Drilling Returns 106.8 m of 0.5 g/t Au
Published on 09/23/2026 at 04:45, 3 hours 51 minutes ago SAINT BELLA Marks First Anniversary at Waldorf Astoria Monarch Beach
Published on 09/23/2026 at 02:45, 5 hours 51 minutes ago Presentation to Beaver Creek Precious Metals Summit
Published on 09/23/2026 at 02:00, 6 hours 36 minutes ago Battery X Metals Announces up to $1 Million Private Placement Financing to Advance Corporate Growth Initiatives
Published on 09/23/2026 at 08:20, 16 minutes ago ViferaXS Raises €12 Million to Advance Phase II Trial in Chronic Lymphocytic Leukemia and Expand Its Oncology Pipeline
Published on 09/23/2026 at 08:19, 17 minutes ago HPW strengthens Garsten site with new copper wire casting plant and focuses on sustainable production
Published on 09/23/2026 at 07:30, 1 hour 6 minutes ago Pyrum Innovations AG reports results for the first six months of 2026
Published on 09/23/2026 at 08:00, 36 minutes ago Résultats semestriels 2026 - ANR par action : 101,90 €, en progression de 8,18 % - Capitaux propres consolidés : 774,5 M€
Published on 09/22/2026 at 18:00, 14 hours 36 minutes ago Consolidated results for the first half of 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 18:00, 14 hours 36 minutes ago Résultats consolidés du premier semestre 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 17:45, 14 hours 51 minutes ago Imerys-09-2026-information-share-capital-and-voting-rights-as-of-31-August-2026